Everand Logo

Welcome to Everand!

  • NPR

    FDA Grants Emergency Authorization For A 2nd COVID-19 Antibody Treatment

    The experimental cocktail from the biotech company Regeneron is the same drug President Trump got when he was battling the coronavirus this year. It is designed for mild to moderate cases.
    by Matthew S. Schwartz Nov 22, 2020 2 minutes

    One of the experimental drugs that President Trump received while he was battling the coronavirus has been approved for emergency use by the Food and Drug Administration. The drug, made by the biotech company Regeneron, is the second antibody treatment to win emergency use approval from the FDA.

    The treatment combines two

    You’re reading a preview, subscribe to read more.

    More from NPR

    NPR3 min read
    Those Sickened By U.S. Nuclear Testing Program Take Their Fight To Congress
    People who live near the areas where nuclear weapons were tested say their communities still suffer harm and are pressing Congress to renew funding to help them.
    NPR4 min readInternational Relations
    U.S. Military Says Aid Is Now Being Delivered Into Gaza Over A Floating Pier
    The shipment is the first in an operation that U.S. military officials anticipate could scale up to 150 truckloads a day entering the Gaza Strip as Israel presses in on the southern city of Rafah.
    NPR3 min read
    Supreme Court Upholds Funding Structure For Consumer Watchdog Agency
    The opinion was written by Justice Clarence Thomas, who reversed the decision of the 5th Circuit. Justices Neil Gorsuch and Samuel Alito dissented.

    Related Books & Audiobooks